Biological therapies are major contributors
to the rising cost of cancer care.
But it doesn't have to be that way.
At Coherus BioSciences, we're committed to
ensuring patient access to biologics through high-quality biosimilars.
We're developing high-value biosimilar therapies backed by robust support services so that you and your patients don't have to choose between quality and cost.
From benefits verification to co-pay support, patient and provider support services and programs are designed to make our high-value treatments more accessible.
Benefits verification for patient-specific insurance coverage and benefits details
Product-specific coding and billing details and claims
Prior Authorization (PA) facilitation and understanding PA requirements to submit information directly to patient's health plan
PA and claims appeal process and example documentation
Alternative financial support investigation through independent foundations for eligible patients
Reducing out-of-pocket costs for patients who are commercially insured* through the Coherus COMPLETE™ Co-Pay Assistance Program
Providing product to eligible uninsured and underinsured patients through the Patient Assistance Program (PAP)
Replacement product in the event of a qualifying claims denial
through the Product Replacement Program†
A single repository for all programs and services through the
Coherus COMPLETE™ Provider Portal
Field Reimbursement Specialists help secure access
and reimbursement for your patients
* Patients covered under Medicare, Medicaid, or any federal or state program will not be eligible for the Coherus COMPLETE™ Co-Pay Assistance Program.
† A qualifying claims denial occurs when the provider has followed and
documented the approved process.